According to USPTO records, IBM divested over 500 US patent assets, as well as a number of foreign counterparts in Asia, Europe, and elsewhere, to a single Delaware entity in late September 2019; at least one follow-up assignment, executed in November, has also been made public by the USPTO. The assignee appears to be controlled by a familiar name in patent monetization.